GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...

GSK already has technology to develop pandemic vaccine adjuvants and will make this available to enhance the development of a jab against the new strain of coronavirus, dubbed 2019-nCoV.

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.

The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin ...

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio. The purchase ...

"China’s NMPA approves GSK’s Nucala for CRSwNP treatment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in ...

GSK is also working with SK Bioscience on a phase 1/2 study for a vaccine based on self-assembling nanoparticle technology developed by the University of Washington, with funding from CEPI and the ...

British drug maker GSK on Monday said it will buy US biopharmaceutical company IDRx for up to $1.15 billion. The Boston-based biotechnology firm is developing therapeutics for the treatment of ...

GlaxoSmithKline has rejected three Unilever offers to buy its consumer goods division, including one worth £50bn. GSK said the proposals "fundamentally failed" to reflect the value of the ...

Hanon meanwhile is joined at Vicebio by two other ex-GSK staffers – Dr Giovanni Della Cioppa and Dr Jean Smal – who will serve as chief medical officer and chief technology officer ...